Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. (Q34244327)

31 July 2017

title

Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. (English)

1 reference

31 July 2017

1 reference

Hildebrand P

1

1 reference

31 July 2017

Beglinger C

2

1 reference

31 July 2017

Gyr K

3

1 reference

31 July 2017

Jansen JB

4

1 reference

31 July 2017

Rovati LC

5

1 reference

31 July 2017

Zuercher M

6

1 reference

31 July 2017

Lamers CB

7

1 reference

31 July 2017

Setnikar I

8

1 reference

31 July 2017

Stalder GA

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

Journal of Clinical Investigation

31 July 2017

published in

1 reference

31 July 2017

volume

85

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

640-646

1 reference

Human pancreatic and biliary responses to physiological concentrations of cholecystokinin octapeptide.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

What is the maximal effective dose of caerulein in stimulating pancreatic secretion in man?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Anticholecystokinin activities of loxiglumide.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Pharmacokinetics of loxiglumide after single intravenous or oral doses in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Structural features of various proglumide-related cholecystokinin receptor antagonists.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Gastric and cephalic stimulation of human pancreatic polypeptide release

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

The importance of cholinergic tone in the release of pancreatic polypeptide by gut hormones in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Radioimmunoassay of cholecystokinin in human plasma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Proglumide analogues: potent cholecystokinin receptor antagonists.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=296477

Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs

28 October 2018

1 reference

12 December 2020

Role of cholecystokinin in regulation of gastrointestinal motor functions

1 reference

12 December 2020

Enzymic analysis of steroid hormones

1 reference

12 December 2020

Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man

1 reference

12 December 2020

The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog

1 reference

12 December 2020

[A highly sensitive enzyme immunoassay for the determination of pancreatic lipase]

1 reference

12 December 2020

Radioimmunoassay of cholecystokinin in human tissue and plasma

1 reference

12 December 2020

Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output

1 reference

12 December 2020

Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex

1 reference

12 December 2020

In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI114486

1 reference

31 July 2017

1 reference

31 July 2017

1 reference